<p>Nvwm LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第三季度将其在礼来公司（NYSE:LLY - 免费报告）的持股减少了 32.8%。该机构投资者在此期间出售了 1,616 股后，持有 3,307 股礼来公司的股票。Nvwm LLC 在礼来公司的持股在最近报告期末的价值为 2,524,000 美元。</p>
<ul>
<li>礼来的新药数据为 2026 年设定了高风险赌注</li>
</ul>
<p>其他一些机构投资者最近也买卖了 LLY 的股票。Lazard Freres Gestion S.A.S.在第二季度将其在礼来公司的持股增加了 114.3%。Lazard Freres Gestion S.A.S.现在拥有 77,295 股礼来公司的股票，价值 60,253,000 美元，此前在上个季度额外购买了 41,222 股。Precedent Wealth Partners LLC 在第二季度将其在礼来公司的持股增加了 15.3%。Precedent Wealth Partners LLC 现在拥有 294 股礼来公司的股票，价值 229,000 美元，此前在上个季度额外购买了 39 股。Central Pacific Bank Trust Division 在第三季度将其在礼来公司的持股增加了 25.8%。Central Pacific Bank Trust Division 现在拥有 8,990 股礼来公司的股票，价值 6,859,000 美元，此前在上个季度额外购买了 1,843 股。Capital Advisors Inc. OK 在第二季度将其在礼来公司的持股增加了 6.8%。Capital Advisors Inc. OK 现在拥有 6,747 股礼来公司的股票，价值 5,260,000 美元，此前在上个季度额外购买了 429 股。最后，Family CFO Inc 在第二季度收购了礼来公司的新股份，价值 54,000 美元。目前 82.53% 的股票由机构投资者和对冲基金持有。</p>
<p>获取 <strong>礼来公司的</strong> 提醒：</p>
<h2>礼来公司股价上涨 0.0%</h2>
<p>礼来公司周五开盘价为 1,077.26 美元。该公司的 50 日简单移动平均为 986.75 美元，200 日简单移动平均为 841.37 美元。礼来公司的 52 周低点为 623.78 美元，52 周高点为 1,111.99 美元。该公司的市值为 1.02 万亿美元，市盈率为 52.70，市盈增长比率为 1.09，贝塔值为 0.37。该公司的债务与股本比率为 1.71，流动比率为 1.55，速动比率为 1.24。</p>
<ul>
<li>行业轮动：2026 年的两个聪明资金动作</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）最后一次公布季度财报是在 10 月 30 日星期四。该公司报告本季度每股收益（EPS）为 7.02 美元，超出分析师一致预期的 6.42 美元，超出幅度为 0.60 美元。该公司本季度的收入为 176 亿美元，而分析师预期为 160.9 亿美元。礼来公司的净利润率为 30.99%，股本回报率为 109.52%。该公司本季度的收入同比增长 53.9%。去年同期，该公司每股收益为 1.18 美元。礼来公司已将其 2025 财年的指导目标设定为 23.000-23.700 EPS。平均而言，卖方分析师预计礼来公司今年将发布 23.48 的每股收益。</p>
<h2>礼来公司增加股息</h2>
<p>该公司最近还披露了一项季度股息，将于 3 月 10 日（星期二）支付。记录在案的投资者将在 2 月 13 日（星期五）获得 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。这相当于年化 6.92 美元的股息，收益率为 0.6%。除息日期为 2 月 13 日（星期五）。礼来公司的股息支付比率目前为 29.35%。</p>
<h2>分析师评级变动</h2>
<ul>
<li>三家医疗巨头刚刚提高了股息——谁支付得最多</li>
</ul>
<p>几位研究分析师最近对 LLY 股票发布了报告。Cantor Fitzgerald 在 12 月 1 日的研究报告中重申了对礼来公司股票的 “增持” 评级。Wall Street Zen 在 11 月 1 日的研究报告中将礼来公司的股票评级从 “买入” 上调至 “强力买入”。Daiwa Capital Markets 在 12 月 16 日的研究报告中对礼来公司的股票设定了 1,230.00 美元的目标价，并给予该股票 “买入” 评级。Berenberg Bank 在 12 月 2 日的报告中将礼来公司的股票目标价从 830.00 美元上调至 950.00 美元，并给予该公司 “持有” 评级。最后，摩根大通在 11 月 18 日的研究报告中将礼来公司的股票目标价从 1,050.00 美元上调至 1,150.00 美元，并给予该股票 “增持” 评级。四位投资分析师对该股票给予了 “强力买入” 评级，十七位给予了 “买入” 评级，五位给予了 “持有” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 1,155.36 美元。</p>
<p><strong>查看我们关于 LLY 的最新报告</strong></p>
<h2>关于礼来公司</h2>
<p>（免费报告）</p>
<p>礼来公司（NYSE: LLY）是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来公司在北美、欧洲、亚洲及其他地区开展业务并拥有商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票超过礼来公司</li>
<li>华尔街股票挑选者评选 2026 年第一只股票</li>
<li>警报：在 2026 年 1 月之前抛售这 5 只股票！</li>
<li>对人工智能未来的 6.5 亿美元押注</li>
<li>Nvidia x 1,000,000</li>
<li>黄金警报</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>本即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Nvwm LLC 在第三季度减少了对礼来的持股，降幅为 32.8%，目前持有 3,307 股，市值为 2,524,000 美元。其他机构投资者也调整了在礼来的持仓。该公司报告了强劲的季度收益，并提高了股息。分析师对礼来的股票给予了积极的评级，并上调了价格目标</p>

<p>Nvwm LLC reduced its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 32.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,307 shares of the company's stock after selling 1,616 shares during the period. Nvwm LLC's holdings in Eli Lilly and Company were worth $2,524,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Nvwm LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第三季度将其在礼来公司（NYSE:LLY - 免费报告）的持股减少了 32.8%。该机构投资者在此期间出售了 1,616 股后，持有 3,307 股礼来公司的股票。Nvwm LLC 在礼来公司的持股在最近报告期末的价值为 2,524,000 美元。</p>
</div><ul>
<li>Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>礼来的新药数据为 2026 年设定了高风险赌注</li>
</ul>
</div><p>A number of other institutional investors have also recently bought and sold shares of LLY. Lazard Freres Gestion S.A.S. grew its position in Eli Lilly and Company by 114.3% during the 2nd quarter. Lazard Freres Gestion S.A.S. now owns 77,295 shares of the company's stock worth $60,253,000 after acquiring an additional 41,222 shares during the last quarter. Precedent Wealth Partners LLC boosted its stake in Eli Lilly and Company by 15.3% in the second quarter. Precedent Wealth Partners LLC now owns 294 shares of the company's stock worth $229,000 after purchasing an additional 39 shares in the last quarter. Central Pacific Bank Trust Division grew its holdings in shares of Eli Lilly and Company by 25.8% during the third quarter. Central Pacific Bank Trust Division now owns 8,990 shares of the company's stock worth $6,859,000 after purchasing an additional 1,843 shares during the last quarter. Capital Advisors Inc. OK grew its holdings in shares of Eli Lilly and Company by 6.8% during the second quarter. Capital Advisors Inc. OK now owns 6,747 shares of the company's stock worth $5,260,000 after purchasing an additional 429 shares during the last quarter. Finally, Family CFO Inc acquired a new stake in shares of Eli Lilly and Company in the second quarter valued at $54,000. 82.53% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些机构投资者最近也买卖了 LLY 的股票。Lazard Freres Gestion S.A.S.在第二季度将其在礼来公司的持股增加了 114.3%。Lazard Freres Gestion S.A.S.现在拥有 77,295 股礼来公司的股票，价值 60,253,000 美元，此前在上个季度额外购买了 41,222 股。Precedent Wealth Partners LLC 在第二季度将其在礼来公司的持股增加了 15.3%。Precedent Wealth Partners LLC 现在拥有 294 股礼来公司的股票，价值 229,000 美元，此前在上个季度额外购买了 39 股。Central Pacific Bank Trust Division 在第三季度将其在礼来公司的持股增加了 25.8%。Central Pacific Bank Trust Division 现在拥有 8,990 股礼来公司的股票，价值 6,859,000 美元，此前在上个季度额外购买了 1,843 股。Capital Advisors Inc. OK 在第二季度将其在礼来公司的持股增加了 6.8%。Capital Advisors Inc. OK 现在拥有 6,747 股礼来公司的股票，价值 5,260,000 美元，此前在上个季度额外购买了 429 股。最后，Family CFO Inc 在第二季度收购了礼来公司的新股份，价值 54,000 美元。目前 82.53% 的股票由机构投资者和对冲基金持有。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司的</strong> 提醒：</p>
</div><h2>Eli Lilly and Company Trading Up 0.0%</h2>
<div class="lb-trans"><h2>礼来公司股价上涨 0.0%</h2>
</div><p>LLY opened at $1,077.26 on Friday. The firm has a 50 day simple moving average of $986.75 and a 200 day simple moving average of $841.37. Eli Lilly and Company has a fifty-two week low of $623.78 and a fifty-two week high of $1,111.99. The company has a market cap of $1.02 trillion, a price-to-earnings ratio of 52.70, a price-to-earnings-growth ratio of 1.09 and a beta of 0.37. The company has a debt-to-equity ratio of 1.71, a current ratio of 1.55 and a quick ratio of 1.24.</p>
<div class="lb-trans"><p>礼来公司周五开盘价为 1,077.26 美元。该公司的 50 日简单移动平均为 986.75 美元，200 日简单移动平均为 841.37 美元。礼来公司的 52 周低点为 623.78 美元，52 周高点为 1,111.99 美元。该公司的市值为 1.02 万亿美元，市盈率为 52.70，市盈增长比率为 1.09，贝塔值为 0.37。该公司的债务与股本比率为 1.71，流动比率为 1.55，速动比率为 1.24。</p>
</div><ul>
<li>Sector Rotation: 2 Smart Money Moves for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>行业轮动：2026 年的两个聪明资金动作</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last announced its quarterly earnings data on Thursday, October 30th. The company reported $7.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.42 by $0.60. The firm had revenue of $17.60 billion for the quarter, compared to analysts' expectations of $16.09 billion. Eli Lilly and Company had a net margin of 30.99% and a return on equity of 109.52%. The business's revenue for the quarter was up 53.9% on a year-over-year basis. During the same period last year, the firm earned $1.18 earnings per share. Eli Lilly and Company has set its FY 2025 guidance at 23.000-23.700 EPS. On average, sell-side analysts anticipate that Eli Lilly and Company will post 23.48 earnings per share for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最后一次公布季度财报是在 10 月 30 日星期四。该公司报告本季度每股收益（EPS）为 7.02 美元，超出分析师一致预期的 6.42 美元，超出幅度为 0.60 美元。该公司本季度的收入为 176 亿美元，而分析师预期为 160.9 亿美元。礼来公司的净利润率为 30.99%，股本回报率为 109.52%。该公司本季度的收入同比增长 53.9%。去年同期，该公司每股收益为 1.18 美元。礼来公司已将其 2025 财年的指导目标设定为 23.000-23.700 EPS。平均而言，卖方分析师预计礼来公司今年将发布 23.48 的每股收益。</p>
</div><h2>Eli Lilly and Company Increases Dividend</h2>
<div class="lb-trans"><h2>礼来公司增加股息</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Friday, February 13th will be issued a $1.73 dividend. This is a boost from Eli Lilly and Company's previous quarterly dividend of $1.50. This represents a $6.92 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, February 13th. Eli Lilly and Company's dividend payout ratio is currently 29.35%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度股息，将于 3 月 10 日（星期二）支付。记录在案的投资者将在 2 月 13 日（星期五）获得 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。这相当于年化 6.92 美元的股息，收益率为 0.6%。除息日期为 2 月 13 日（星期五）。礼来公司的股息支付比率目前为 29.35%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li>
</ul>
<div class="lb-trans"><ul>
<li>三家医疗巨头刚刚提高了股息——谁支付得最多</li>
</ul>
</div><p>Several research analysts recently issued reports on LLY shares. Cantor Fitzgerald reiterated an &#34;overweight&#34; rating on shares of Eli Lilly and Company in a research report on Monday, December 1st. Wall Street Zen raised shares of Eli Lilly and Company from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, November 1st. Daiwa Capital Markets set a $1,230.00 target price on shares of Eli Lilly and Company and gave the stock a &#34;buy&#34; rating in a research report on Tuesday, December 16th. Berenberg Bank raised their price target on shares of Eli Lilly and Company from $830.00 to $950.00 and gave the company a &#34;hold&#34; rating in a report on Tuesday, December 2nd. Finally, JPMorgan Chase &amp; Co. boosted their price objective on shares of Eli Lilly and Company from $1,050.00 to $1,150.00 and gave the stock an &#34;overweight&#34; rating in a research report on Tuesday, November 18th. Four investment analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $1,155.36.</p>
<div class="lb-trans"><p>几位研究分析师最近对 LLY 股票发布了报告。Cantor Fitzgerald 在 12 月 1 日的研究报告中重申了对礼来公司股票的 “增持” 评级。Wall Street Zen 在 11 月 1 日的研究报告中将礼来公司的股票评级从 “买入” 上调至 “强力买入”。Daiwa Capital Markets 在 12 月 16 日的研究报告中对礼来公司的股票设定了 1,230.00 美元的目标价，并给予该股票 “买入” 评级。Berenberg Bank 在 12 月 2 日的报告中将礼来公司的股票目标价从 830.00 美元上调至 950.00 美元，并给予该公司 “持有” 评级。最后，摩根大通在 11 月 18 日的研究报告中将礼来公司的股票目标价从 1,050.00 美元上调至 1,150.00 美元，并给予该股票 “增持” 评级。四位投资分析师对该股票给予了 “强力买入” 评级，十七位给予了 “买入” 评级，五位给予了 “持有” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 1,155.36 美元。</p>
</div><p><strong>View Our Latest Report on LLY</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 LLY 的最新报告</strong></p>
</div><h2>About Eli Lilly and Company</h2>
<div class="lb-trans"><h2>关于礼来公司</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company NYSE: LLY is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.</p>
<div class="lb-trans"><p>礼来公司（NYSE: LLY）是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来公司在北美、欧洲、亚洲及其他地区开展业务并拥有商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>Wall Street Stockpicker Names #1 Stock of 2026</li>
<li>ALERT: Drop these 5 stocks before January 2026!</li>
<li>The $650 Million Bet on AI's Future</li>
<li>Nvidia x 1,000,000</li>
<li>GOLD ALERT</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过礼来公司</li>
<li>华尔街股票挑选者评选 2026 年第一只股票</li>
<li>警报：在 2026 年 1 月之前抛售这 5 只股票！</li>
<li>对人工智能未来的 6.5 亿美元押注</li>
<li>Nvidia x 1,000,000</li>
<li>黄金警报</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>本即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Nvwm LLC 减少了对礼来公司 $LLY 的持股量